U.S. markets closed
  • S&P Futures

    3,632.25
    +5.00 (+0.14%)
     
  • Dow Futures

    29,872.00
    +44.00 (+0.15%)
     
  • Nasdaq Futures

    12,179.75
    +27.50 (+0.23%)
     
  • Russell 2000 Futures

    1,850.80
    +6.20 (+0.34%)
     
  • Crude Oil

    45.79
    +0.08 (+0.18%)
     
  • Gold

    1,808.50
    +3.00 (+0.17%)
     
  • Silver

    23.42
    +0.06 (+0.25%)
     
  • EUR/USD

    1.1927
    +0.0009 (+0.07%)
     
  • 10-Yr Bond

    0.8780
    -0.0040 (-0.45%)
     
  • Vix

    21.25
    -0.39 (-1.80%)
     
  • GBP/USD

    1.3390
    +0.0008 (+0.06%)
     
  • USD/JPY

    104.3050
    -0.1350 (-0.13%)
     
  • BTC-USD

    18,813.25
    -29.88 (-0.16%)
     
  • CMC Crypto 200

    370.44
    -0.08 (-0.02%)
     
  • FTSE 100

    6,391.09
    -41.08 (-0.64%)
     
  • Nikkei 225

    26,441.10
    +144.24 (+0.55%)
     

Xenon Pharmaceuticals: 3Q Earnings Snapshot

·1 min read

BURNABY, British Columbia (AP) _ Xenon Pharmaceuticals Inc. (XENE) on Thursday reported a loss of $8.9 million in its third quarter.

The Burnaby, British Columbia-based company said it had a loss of 25 cents per share.

The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 15 cents per share.

The gene therapy biotech company posted revenue of $6.6 million in the period, also missing Street forecasts. Five analysts surveyed by Zacks expected $10.3 million.

Xenon Pharmaceuticals shares have fallen nearly 10% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $11.85, a climb of 30% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XENE at https://www.zacks.com/ap/XENE